title: Therapeutic angiogenesis for critical limb ischemia to limit or avoid amputation.
authors.affiliation: Medical College of Wisconsin, University of Wisconsin Medical School, Department of Cardiovascular Medicine, 9200 West Wisconsin Avenue, Milwaukee, WI, 53226, USA.
authors.forename: N
authors.initials: N
authors.lastname: Kipshidze
authors.forename: V
authors.initials: V
authors.lastname: Chekanov
authors.forename: S
authors.initials: S
authors.lastname: Kappes
authors.forename: A
authors.initials: A
authors.lastname: Abdurahman
authors.forename: D
authors.initials: D
authors.lastname: Hammen
authors.forename: P S
authors.initials: PS
authors.lastname: Chawla
authors.forename: V
authors.initials: V
authors.lastname: Nikolaychik
authors.forename: C
authors.initials: C
authors.lastname: Haudenschild
authors.forename: M H
authors.initials: MH
authors.lastname: Keelan
mesh_terms: D000671:Amputation, Surgical; D043925:Angiogenesis Inducing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007511:Ischemia / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D007866:Leg / Q000098:blood supply*; D008875:Middle Aged; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D042461:Vascular Endothelial Growth Factor A / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D043925:Angiogenesis Inducing Agents; D015718:Fibrin Tissue Adhesive; D042461:Vascular Endothelial Growth Factor A